Aug 10 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS Q2 2018 RESULTS
* Q2 EARNINGS PER SHARE $0.07 FROM CONTINUING OPERATIONS
* Q2 REVENUE $7.0 MILLION VERSUS $9.9 MILLION
* EXPECTS ITS LICENSING BUSINESS TO PROVIDE A SOLID BASE OF HIGH-MARGIN ROYALTY REVENUE IN 2018